Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Fujimoto

Showing results (181-190 of 183) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 183 results.
Cancer|June 24, 2020
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trialKazuto Ito, Mikio Kobayashi, Motokiyo Komiyama, et al.
Cancer Medicine|May 1, 2021
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trialAkira Yokomizo, Hirofumi Koga, Kazuto Ito, et al.
JNCI Cancer Spectrum|November 25, 2022
Prediction of tissue-of-origin of early stage cancers using serum miRNomesJuntaro Matsuzaki, Ken Kato, Kenta Oono, et al.
Pageof 19

Showing results (181-190 of 183) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 183 results.
Cancer|June 24, 2020
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trialKazuto Ito, Mikio Kobayashi, Motokiyo Komiyama, et al.
Cancer Medicine|May 1, 2021
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trialAkira Yokomizo, Hirofumi Koga, Kazuto Ito, et al.
JNCI Cancer Spectrum|November 25, 2022
Prediction of tissue-of-origin of early stage cancers using serum miRNomesJuntaro Matsuzaki, Ken Kato, Kenta Oono, et al.
Pageof 19